SHAVONNE DOYLE: Open Payments
NPI 1013596089 · OXFORD, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$197 in 7 payments from 6 companies in 2025. Trend: 2023 $4,362 · 2024 $3,514 · 2025 $197
Food & beverage: $197
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 1 | $85 |
| ABBVIE INC. | 2 | $36 |
| PFIZER INC. | 1 | $28 |
| Boston Scientific Corporation | 1 | $18 |
| Novartis Pharmaceuticals Corporation | 1 | $15 |
| ARGENX US, INC. | 1 | $15 |
Products named: REXULTI, OCTAGAM IMMUNE GLOBULIN (HUMAN), VYALEV, General - Pain Management, UBRELVY, KESIMPTA, VYVGART HYTRULO.
Industry payments across MS — which companies pay providers there.
